Improved delivery through biological membranes LX: Intradermal targeting of acyclovir using redox-based chemical drug delivery systems

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 3, Issue 1, 1996, Pages 17-26

  Chikhale, Prashant J ^a   Venkatraghavan, Vasu ^a   Bodor, Nicholas S ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Acyclovir; Biological stability; Intradermal drug targeting; Oxidation; Redox based chemical drug delivery systems; Reduction; Skim membrane partitioning

Indexed keywords

1 METHYL 3 [(9' GUANYLMETHOXYETHOXY)CARBONYL] 1,4 DIHYDROPYRIDINE; 1 METHYL 3 [(9' GUANYLMETHOXYETHOXY)CARBONYL]PYRIDINIUM IODIDE; 1 METHYL PYRIDINE 3 CARBOXYLIC ACID ANHYDRIDE DIIODIDE; 1,4 DIHYDROTRIGONELLINE; ACICLOVIR; ACICLOVIR ALPHA LIPOIC ACID ESTER; ANTIVIRUS AGENT; THIOCTIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INTRADERMAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; OXIDATION; OXIDATION REDUCTION STATE; PARTITION COEFFICIENT; PHARMACEUTICS; PRIORITY JOURNAL; REDUCTION; SKIN PENETRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0029945352     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.3109/10717549609031377     Document Type: Article

References (34)

1. Elion, G. B., Furman, P. A., Fyfe, J. A., de Miranda, P., Beauchamp, L., and Schaefer, H. J. (1977) Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proc. Natl. Acad. Sci. USA 74:5716-5720.
2. Schaefer, H. L., Beauchamp, L., de Miranda, P., Elion, G. B., Bauer, D. J., and Collins, P. (1978) 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group. Nature 272:583-585.
3. Spruance, S. L., Schnipper, L. D., Overall, J. C., Jr., Kern, E. R., Wester, B., Modlin, J., Wenerstrom, G., Burton, C., Arndt, K. A., Chice, G. L., and Crumpacker, C. S. (1982) Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J. Infect. Dis. 146:85-90.
4. Fiddian, A. P., Yeo, J. M., Stubbings, R., and Dean, D. (1983) Successful treatment of herpes labialis with topical acyclovir. Br. Med. J. 286:1699-1701.
5. Krasny, H. C., De Miranda, P., Blum, M. R., and Elion, G. B. (1981) Pharmacokinetics and bioavailability of acyclovir in the dog. J. Pharmacol. Exp. Ther. 216:281-288.
6. Yeo, J. M., and Fiddian, A. P. (1983) Acyclovir in the management of herpes labialis. J. Antimicrob. Chemother. 12(Suppl. B):95-103.
7. Martin, J. C., Tippie, M. A., McGee, D. P. C., and Verheyden, J. P. H. (1987) Synthesis and antiviral activity of various esters of 9-[(1,3-dihydroxy2-propoxy)methyl]guanine. J. Phann. Sci. 76:180-184.
8. Bundgaard, H., Jensen, E., and Falch, E. (1991) Water-soluble, solution-stable, and biolabile N-substituted (aminomethyl)benzoate ester prodrugs of acyclovir. Pharm. Res. 8:1087-1093.
9. Chikhale, P. J., and Bodor, N. S. (1991) Improved delivery of acyclovir to the skin using a dihydrotrigonelline-trigonelline redox carrier. J. Pharm. Sci. 80:402-403.
10. Colla, L., De Clerq, E., Busson, R., and Vanderhaeghe, H. (1983) Synthesis and antiviral activity of water-soluble esters of acyclovir [9-[(2-hydroxyethoxy)methyl]guanine]. J. Med. Chem. 26:602-604.
11. Kenley, R. A., Jackson, S. E., Winterle, J. S., Shunko, Y., and Visor, G. C. (1986) Water soluble complexes of the antiviral drugs, 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine and acyclovir: the role of hydrophobicity in complex formation. J. Pharm. Sci. 75:648-653.
12. Good, S. S., Krasny, H. C., Elion, G. B., and De Miranda, P. (1983). Disposition in the dog and the rat of 2,6-diamino-9-(2-hydroxyethoxymethyl)purine (A134U), a potential prodrug of acyclovir. J. Pharmacol. Exp. Ther. 227:644-651.
13. Spector, T., Jones, T. E., and Beauchamp, L. M. (1983) Conversion of 2,6-diamino-9-(2-hydroxyethoxymethyl)purine to acyclovir as catalyzed by adenosine deaminase. Biochem. Pharmacol. 32:2505-2509.
14. Krenitsky, T. A., Hall, W. W., De Miranda, P., Beauchamp, L. M., Schaeffer, H. J., and Whiteman, P. D. (1984) 6-Deoxyacyclovir: a xanthine-oxidase activated prodrug of acyclovir. Proc. Natl. Acad. Sci. USA 81:3209-3213.
15. Selby, P., Blake, S., Mbidde, E. K., Hickmott, E., Powles, R. L., Stolle, K., McElwain, T. J., Whiteman, P. D., and Fiddian, A. P. (1984) Amino(hydroxyethoxymethyl)purine: a new well-absorbed prodrug of acyclovir. Lancet 2:1428-1430.
16. Whiteman, P. D., Bye, A., Fowle, A. S. E., Jeal, S., Land, G., and Posner, J. (1984) Tolerance and pharmacokinetics of A515U, an acyclovir analogue, in healthy volunteers. Eur. J. Clin. Pharmacol. 27:471-475.
17. Maudgal, P. C., De Clerq, E., Descamps, J., and Missotten, L. (1984) Topical treatment of experimental herpes simplex keratouveitis with 2′-O-glycylacyclovir. Arch. Ophthalmol. 102:140-142.
18. Corey, L., Nahmais, A. J., Guinan, M. E., Benedetti, J. K., Critchlow, C. W., and Holmes, K. K. (1982) A trial of topical acyclovir in genital herpes simplex virus infection. N. Engl. J. Med. 306:1313-1319.
19. Shaw, M., King, M., Best, J. M., Banatvala, J. E., Gibson, J. R., and Klaber, M. R. (1985) Failure of acyclovir cream in treatment of recurrent herpes labialis. Br. Med. J. 291:7-9.
20. Freeman, D. J., Sheth, N. V., and Spruance, S. L. (1986) Failure of topical acyclovir in ointment to penetrate human skin. Antimicrob. Agents Chemother. 29:730-732.
21. Chikhale, P. J., Marvanyos, E., and Bodor, N. S. (1994) Improved delivery through biological membranes, LXI: design, synthesis and evaluation of a lipoic-acid based intradermal drug targeting system for 5-fluorouracil. Cancer Biother. 9:245-252.
22. Brewster, M. E., Venkatraghavan, V., Shek, E., and Bodor, N. (1987) Facile one-step preparation of trigonellinate esters. Synth. Commun. 17:451-155 (1987).
23. Lee, G., and Parlicharla, P. (1986) An examination of excised skin tissues used for in vitro membrane permeation studies. Pharm. Res. 3:356-359.
24. Bodor, N., and Kaminski, J. (1988) Correlation between hydride transfer and one-electron oxidation of dihydropyridines and heterocycles. J. Mol. Struct. (Theochem.) 163:315-330.
25. Bodor, N., Sloan, K. B., Little, R. J., Selk, S. H., and Caldwell, L. (1982) Soft drugs, 4: Spirothiazolidines of hydrocortisone and its derivatives. Int. J. Pharm. 10:307-321.
26. Bodor, N. (1982) Soft drugs: strategies for design of safer drugs. In: Strategy in Drug Research. J. A. K. Buisman, Ed. Elsevier, New York, pp. 137-164.
27. Bodor, N., and Sloan, K. B. (1982) Soft drugs, V: thiazolidine-type derivatives of progesterone and testosterone. J. Pharm. Sci. 71:514-520.
28. Fyfe, J. A., Keller, P. M., Furman, P. A., Miller, R. L., and Elion, G. B. (1978) Thymidine kinase from herpes simplex virus phosphorylates: the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J. Biol. Chem. 253:8721-8727.
29. Furman, P. A., St. Clair, M. H., Fyfe, J. A., Rideout, J. L., Keller, P. M., and Elion, G. B. (1979) Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate. J. Virol. 32:72-77.
30. Halprin, K. M., and Ohkawara, A. (1966) Glucose utilization in the human epidermis: its control by hexokinase. J. Invest. Derm. 46:278-282.
31. Adachi, K., and Yamasawa, S. (1966) Quantitative histochemistry of the primate skin, 1: hexokinase. J. Invest. Derm. 46:473-176.
32. Minick, D. J., Frenz, J. H., Patrick, M. A., and Brent, D. A. (1988) A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography. J. Med. Chem. 31:1923-1933.
33. Eisner, U., and Kuthan, J. (1972) The chemistry of dihydropyridines. Chem. Rev. 72:1-12.
34. Lyle, R. E., and Anderson, P. S. (1966) The reduction of nitrogen heterocycles with complex metal hydrides. Adv. Heterocycl. Chem. 6:45-93.